The Latest Breaking News from StockNews.com

The entertainment casino industry is benefiting from the unprecedented growth of online gambling activities, rising disposable income, and easy accessibility. Therefore, let’s delve into the fundamentals of entertainment casino stocks Monarch Casino & Resort (MCRI) and DraftKings (DKNG) to gauge their suitability as portfolio additions. Read on….

With increased automation of business operations across several industries, the rising need for customized apps and data security, and technological advancements, the software sector is flourishing. Hence, it could be ideal to watch robust software stocks Akamai Technologies (AKAM), SS&C Technologies (SSNC), and Qualys (QLYS) this week, which have huge…

The pharmaceutical industry holds immense promise due to the rapidly aging population, growing healthcare needs, breakthroughs in new drugs and therapies, and the rise in chronic diseases. Therefore, it could be wise to add fundamentally strong pharma stocks Supernus Pharmaceuticals (SUPN), Eton Pharmaceuticals (ETON), and Viatris (VTRS) to one’s portfolio.…

The semiconductor industry shows great potential for future prosperity amid rising integration of advanced technology, growing chip demand across sectors, and government support. To that end, fundamentally robust chip stocks Amkor Technology (AMKR), United Microelectronics Corporation (UMC), and Infineon Technologies AG (IFNNY) could be solid buys to guard the portfolio…

A wide range of applications across several sectors, supportive government initiatives, rapid technological advancements, and shifting market dynamics position the biotechnology industry for robust long-term growth. Given the industry’s bright outlook, biotech stocks MannKind (MNKD), Illumina (ILMN), and TG Therapeutics (TGTX) could be ideal watchlist additions for potential growth. Read…

The pharmaceutical industry, which experienced significant growth over the past years, is anticipated to remain buoyed, driven by the increasing prevalence of chronic diseases, advancements in medical technology, and rising healthcare awareness and expenditure. Given this backdrop, quality pharma stocks Voyager Therapeutics (VYGR), Sanofi (SNY), and Pacira BioSciences (PCRX), with…

Chipmaker QUALCOMM (QCOM) reported an earnings beat amid a recovering semiconductor market. Let’s look at its financial metrics to gauge whether the stock is exhibiting buy signals. Read on….

The pharma industry embraces digital trends and advancements in clinical research in 2024, with prospects of significant expansion. Hence, fundamentally strong pharma stocks Dr. Reddy's Laboratories (RDY), Amneal Pharmaceuticals (AMRX), and AbbVie (ABBV) might be worth adding to one’s watchlist. Read more….

The chip industry is rebounding, fueled by recovering demand, increased need for AI chips, and capacity expansions in advanced technologies. To that end, renowned chip stocks ASE Technology (ASX), QUALCOMM (QCOM), and Photronics (PLAB), which are now popular among investors, could be wise additions to your portfolio. Read more.

The evolution of the internet, combined with immersive technologies and the ascent of generative AI, marks a transformative era. In this context, which internet stock, Meta Platforms (META) or Snap Inc. (SNAP), is poised to deliver superior returns against this backdrop? Let’s find out….

While AbbVie (ABBV) saw a decrease in net revenues and EPS in the last reported quarter, it raised its 2023 adjusted EPS guidance range. With the company gearing up to report fourth-quarter 2023 results tomorrow, is the stock worth buying today? Keep reading.